- Home
- RLAY vs JELD Comparison
RLAY vs JELD Comparison
Compare RLAY & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- JELD
- Stock Information
- Founded
- RLAY 2015
- JELD 1960
- Country
- RLAY United States
- JELD United States
- Employees
- RLAY N/A
- JELD N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- JELD Forest Products
- Sector
- RLAY Health Care
- JELD Basic Materials
- Exchange
- RLAY Nasdaq
- JELD Nasdaq
- Market Cap
- RLAY 811.8M
- JELD 707.4M
- IPO Year
- RLAY 2020
- JELD 2017
- Fundamental
- Price
- RLAY $3.92
- JELD $5.95
- Analyst Decision
- RLAY Strong Buy
- JELD Hold
- Analyst Count
- RLAY 10
- JELD 8
- Target Price
- RLAY $20.11
- JELD $12.44
- AVG Volume (30 Days)
- RLAY 1.4M
- JELD 1.0M
- Earning Date
- RLAY 02-28-2025
- JELD 02-17-2025
- Dividend Yield
- RLAY N/A
- JELD N/A
- EPS Growth
- RLAY N/A
- JELD N/A
- EPS
- RLAY N/A
- JELD N/A
- Revenue
- RLAY $10,006,000.00
- JELD $3,775,600,000.00
- Revenue This Year
- RLAY N/A
- JELD N/A
- Revenue Next Year
- RLAY N/A
- JELD N/A
- P/E Ratio
- RLAY N/A
- JELD N/A
- Revenue Growth
- RLAY N/A
- JELD N/A
- 52 Week Low
- RLAY $3.50
- JELD $5.79
- 52 Week High
- RLAY $10.89
- JELD $21.75
- Technical
- Relative Strength Index (RSI)
- RLAY 41.60
- JELD 25.37
- Support Level
- RLAY $3.85
- JELD $5.79
- Resistance Level
- RLAY $4.19
- JELD $9.15
- Average True Range (ATR)
- RLAY 0.28
- JELD 0.53
- MACD
- RLAY -0.02
- JELD -0.33
- Stochastic Oscillator
- RLAY 24.80
- JELD 4.56
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.